Aromatase inhibitors: treatment of advanced breast cancer.
Panasci
L C
LC
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D047072:Aromatase Inhibitors; D015519:Bone Density / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077289:Letrozole; D008875:Middle Aged; D009570:Nitriles / Q000009:adverse effects* / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077289:Letrozole